VOXZOGO Trademark

Trademark Overview

On Tuesday, December 17, 2019, a trademark application was filed for VOXZOGO with the United States Patent and Trademark Office. The USPTO has given the VOXZOGO trademark a serial number of 88730610. The federal status of this trademark filing is REGISTERED as of Tuesday, March 29, 2022. This trademark is owned by Biomarin Pharmaceutical Inc.. The VOXZOGO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of genetic diseases and disorders
voxzogo

General Information

Serial Number88730610
Word MarkVOXZOGO
Filing DateTuesday, December 17, 2019
Status700 - REGISTERED
Status DateTuesday, March 29, 2022
Registration Number6687387
Registration DateTuesday, March 29, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 9, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of genetic diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 20, 2019
Primary Code005
First Use Anywhere DateSunday, December 12, 2021
First Use In Commerce DateSunday, December 12, 2021

Trademark Owner History

Party NameBiomarin Pharmaceutical Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNovato, CA 94949
Party NameBiomarin Pharmaceutical Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNovato, CA 94949
Party NameBiomarin Pharmaceutical Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNovato, CA 94949

Trademark Events

Event DateEvent Description
Friday, December 20, 2019NEW APPLICATION ENTERED
Friday, December 20, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 13, 2020ASSIGNED TO EXAMINER
Thursday, April 16, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 16, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 5, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 16, 2020NON-FINAL ACTION WRITTEN
Monday, March 16, 2020NON-FINAL ACTION E-MAILED
Monday, March 16, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 9, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 16, 2020ASSIGNED TO LIE
Wednesday, May 20, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 9, 2020PUBLISHED FOR OPPOSITION
Tuesday, June 9, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 4, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 12, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, January 12, 2021SOU EXTENSION 1 FILED
Tuesday, January 12, 2021SOU EXTENSION 1 GRANTED
Thursday, January 14, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 30, 2021SOU EXTENSION 2 FILED
Friday, July 30, 2021SOU TEAS EXTENSION RECEIVED
Friday, July 30, 2021SOU EXTENSION 2 GRANTED
Tuesday, August 3, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 6, 2022SOU TEAS EXTENSION RECEIVED
Thursday, January 6, 2022SOU EXTENSION 3 FILED
Thursday, January 6, 2022SOU EXTENSION 3 GRANTED
Monday, January 10, 2022TEAS STATEMENT OF USE RECEIVED
Saturday, January 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 10, 2022USE AMENDMENT FILED
Tuesday, January 25, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 25, 2022STATEMENT OF USE PROCESSING COMPLETE
Wednesday, February 23, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, February 24, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 29, 2022REGISTERED-PRINCIPAL REGISTER

Related Keywords

voxzogo diseases disorders genetic treatment preparations pharmaceutical